Further on February 24 to 28 this year, 15 laboratory personnel were trained on HLA testing and gaining hands-on experience with the newly acquired equipment ...
13h
News-Medical.Net on MSNIn the Thymus We Trust: ProTcell Therapy & the Future of Allogeneic ImmunotherapyIn this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy is being revolutionized.
Bengaluru (Karnataka) [India], March 11: In keeping with the theme of International Women's Day, "Accelerate Action", DKMS Foundation India encourages empowering women to take leadership roles in ...
Captain Salman Ali Agha made 46 as Pakistan reached 135-9 in a match reduced to 15 overs per innings after a delay for wet ...
1d
GlobalData on MSNAnocca gains European authorisation for Phase I/II trial of pancreatic cancer drugAnocca has secured authorisation from regulatory authorities in four European nations for its Phase I/II VIDAR-1 clinical ...
CTA approval marks Anocca’s transition to a clinical-stage companyFirst-in-human VIDAR-1 trial begins with the deployment of ...
Study finds antibodies that target Epstein-Barr virus proteins can also attack proteins in the brain, increasing the ...
European regulators have cleared Anocca to begin a Phase I/II umbrella trial of its lead targeted T-cell receptor (TCR) therapy ANOC-001 and other pipeline candidates in certain advanced pancreatic ...
6d
Bangkok Post on MSNBroadway Fantasy Takes Over THE MALL LIFESTORE SUMMER-CATIONTHE MALL LIFESTORE, in collaboration with over 120 leading fashion brands and business partners, proudly presents 'THE MALL LIFESTORE SUMMER-CATION: The Ultimate Summer Fashion Extravaganza'. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results